Jane Huang
President en PRELUDE THERAPEUTICS INCORPORATED .
Fortuna: 243 246 $ al 31/03/2024
Perfil
La Dra. Jane E. Huang, MD, es directora médica de hematología en BeiGene Ltd. Anteriormente, la Dra. Huang trabajó como Vicepresidenta y Jefa de Desarrollo Clínico en Acerta Pharma BV y como Directora Médica de Grupo en Genentech, Inc. Se licenció en la Universidad de Stanford y se doctoró en la Facultad de Medicina de la Universidad de Washington.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 04/04/2024 | 51 287 ( 0.09% ) | 243 100 $ | 31/03/2024 | |
BEIGENE LTD
0.00% | 17/04/2023 | 12 ( 0.00% ) | 146 $ | 31/03/2024 |
| 07/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Cargos activos de Jane Huang
| Empresas | Cargo | Inicio |
|---|---|---|
| PROTARA THERAPEUTICS, INC. | Director/Board Member | 09/06/2021 |
| PRELUDE THERAPEUTICS INCORPORATED | President | 04/04/2022 |
858 Therapeutics, Inc.
 858 Therapeutics, Inc. BiotechnologyHealth Technology 858 Therapeutics, Inc. operates as a pharmaceutical company. The company was founded in 2019 and is headquartered in San Diego, CA. | Director/Board Member | 05/04/2022 |
Antiguos cargos conocidos de Jane Huang.
| Empresas | Cargo | Fin |
|---|---|---|
| BEIGENE, LTD. | Chief Tech/Sci/R&D Officer | 03/04/2022 |
Acerta Pharma BV
 Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | Corporate Officer/Principal | 01/09/2016 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/03/2015 |
Formación de Jane Huang.
| Stanford University | Undergraduate Degree |
| Washington University School of Medicine | Doctorate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| BEIGENE, LTD. | Health Technology |
| PRELUDE THERAPEUTICS INCORPORATED | Health Technology |
| PROTARA THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | Health Technology |
858 Therapeutics, Inc.
858 Therapeutics, Inc. BiotechnologyHealth Technology 858 Therapeutics, Inc. operates as a pharmaceutical company. The company was founded in 2019 and is headquartered in San Diego, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Jane Huang
